Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nicholls

Showing results (1311-1320 of 1,396) with videos related to

Pageof 140
Sort By:
Lancet (London, England)|April 25, 2003
Coronavirus as a possible cause of severe acute respiratory syndromeJ S M Peiris, S T Lai, L L M Poon, et al.
Science Advances|July 3, 2021
The mitochondrial single-stranded DNA binding protein is essential for initiation of mtDNA replicationMin Jiang, Xie Xie, Xuefeng Zhu, et al.
Nature|May 8, 2024
Discovery of potent small-molecule inhibitors of lipoprotein(a) formationNuria Diaz, Carlos Perez, Ana Maria Escribano, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 1, 2023
Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formationNisha Schwarz, Sanuja Fernando, Yung-Chih Chen, et al.
Heart, Lung & Circulation|August 26, 2020
Lack of Strategic Funding and Long-Term Job Security Threaten to Have Profound Effects on Cardiovascular Researcher Retention in AustraliaRachel E Climie, Jason H Y Wu, Anna C Calkin, et al.
American Heart Journal|October 16, 2020
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarctionC Michael Gibson, John J P Kastelein, Adam T Phillips, et al.
Open Heart|October 17, 2022
Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular diseaseSteven E Nissen, Kathy Wolski, Leslie Cho, et al.
Journal of Atherosclerosis and Thrombosis|March 28, 2017
Design of the Familial Hypercholesterolaemia Australasia Network Registry: Creating Opportunities for Greater International CollaborationMatthew I Bellgard, Caroline E Walker, Kathryn R Napier, et al.
Journal of the American College of Cardiology|March 29, 2020
2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary PlaquesMyong Hwa Yamamoto, Akiko Maehara, Gregg W Stone, et al.
JACC. Asia|November 7, 2022
Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific RegionHayato Tada, Khung Keong Yeo, Jian-Jun Li, et al.
Pageof 140

Showing results (1311-1320 of 1,396) with videos related to

Sort By:
Pageof 140
Lancet (London, England)|April 25, 2003
Coronavirus as a possible cause of severe acute respiratory syndromeJ S M Peiris, S T Lai, L L M Poon, et al.
Science Advances|July 3, 2021
The mitochondrial single-stranded DNA binding protein is essential for initiation of mtDNA replicationMin Jiang, Xie Xie, Xuefeng Zhu, et al.
Nature|May 8, 2024
Discovery of potent small-molecule inhibitors of lipoprotein(a) formationNuria Diaz, Carlos Perez, Ana Maria Escribano, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 1, 2023
Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formationNisha Schwarz, Sanuja Fernando, Yung-Chih Chen, et al.
Heart, Lung & Circulation|August 26, 2020
Lack of Strategic Funding and Long-Term Job Security Threaten to Have Profound Effects on Cardiovascular Researcher Retention in AustraliaRachel E Climie, Jason H Y Wu, Anna C Calkin, et al.
American Heart Journal|October 16, 2020
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarctionC Michael Gibson, John J P Kastelein, Adam T Phillips, et al.
Open Heart|October 17, 2022
Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular diseaseSteven E Nissen, Kathy Wolski, Leslie Cho, et al.
Journal of Atherosclerosis and Thrombosis|March 28, 2017
Design of the Familial Hypercholesterolaemia Australasia Network Registry: Creating Opportunities for Greater International CollaborationMatthew I Bellgard, Caroline E Walker, Kathryn R Napier, et al.
Journal of the American College of Cardiology|March 29, 2020
2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary PlaquesMyong Hwa Yamamoto, Akiko Maehara, Gregg W Stone, et al.
JACC. Asia|November 7, 2022
Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific RegionHayato Tada, Khung Keong Yeo, Jian-Jun Li, et al.
Pageof 140